, Tracking Stock Market Picks
Enter Symbol:
Vertex Pharmaceuticals Incorporated (VRTX) [hlAlert]

up 190.63 %

Vertex Pharmaceuticals Incorporated (VRTX) upgraded to Outperform with price target $53 by Robert W. Baird

Posted on: Thursday,  Feb 7, 2013  8:25 AM ET by Robert W. Baird

Robert W. Baird rated Outperform Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on 02/07/2013, when the stock price was $46.02.
Since then, Vertex Pharmaceuticals Incorporated has gained 190.63% as of 12/01/2015's recent price of $133.75.
If you would have followed this Robert W. Baird's recommendation on VRTX, you would have gained 190.63% of your investment in 1027 days.

Vertex Pharmaceuticals Inc. discovers, develops and markets small molecule drugs that address major unmet medical needs. The company has eight drug candidates in clinical development to treat viral diseases, inflammation, cancer, autoimmune diseases and neurological disorders. Vertex has created its pipeline using a proprietary information-based approach to drug design that integrates multiple technologies in biology, chemistry and biophysics aimed at increasing the speed and success rate of drug discovery. (PRESS RELEASE)

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/7/2013 8:25 AM Buy
46.02 53.00
as of 12/13/2013
1 Week down  -1.91 %
1 Month up  6.50 %
3 Months down  -16.70 %
1 YTD up  41.63 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/8/2011 8:25 AM Hold
31.80 33.00
4/1/2008 8:25 AM Buy
24.27 33.00
1/15/2008 8:25 AM Hold
22.73 25.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy